Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Clin Gastroenterol Hepatol ; 17(12): 2608-2609.e1, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-30664949

RESUMEN

Pain is the most common and most debilitating aspect of chronic pancreatitis and is difficult to treat.1-3 Clinical management of painful chronic pancreatitis includes abstinence from alcohol and tobacco products, analgesic medications (including opioids), antidepressant medications, and pancreatic enzyme replacement.4-8 Medical cannabis has been proposed as a therapy for chronic pain and has shown some efficacy in neuropathic and cancer pain. In this study, we investigated the efficacy of medical cannabis on pain control for chronic pancreatitis.


Asunto(s)
Analgésicos Opioides/uso terapéutico , Dolor Crónico/tratamiento farmacológico , Prescripciones de Medicamentos/estadística & datos numéricos , Marihuana Medicinal/uso terapéutico , Pancreatitis Crónica/tratamiento farmacológico , Estudios de Cohortes , Servicio de Urgencia en Hospital/estadística & datos numéricos , Humanos , New Hampshire/epidemiología , Admisión del Paciente/estadística & datos numéricos , Estudios Retrospectivos , Vermont/epidemiología
2.
J Altern Complement Med ; 24(6): 552-556, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29470104

RESUMEN

OBJECTIVE: Pain relief resulting from services delivered by doctors of chiropractic may allow patients to use lower or less frequent doses of opioids, leading to reduced risk of adverse effects. The objective of this investigation was to evaluate the association between utilization of chiropractic services and the use of prescription opioid medications. DESIGN: The authors used a retrospective cohort design to analyze health insurance claims data. SETTING: The data source was the all payer claims database administered by the State of New Hampshire. The authors chose New Hampshire because health claims data were readily available for research, and in 2015, New Hampshire had the second-highest age-adjusted rate of drug overdose deaths in the United States. SUBJECTS: The study population comprised New Hampshire residents aged 18-99 years, enrolled in a health plan, and with at least two clinical office visits within 90 days for a primary diagnosis of low-back pain. The authors excluded subjects with a diagnosis of cancer. OUTCOME MEASURES: The authors measured likelihood of opioid prescription fill among recipients of services delivered by doctors of chiropractic compared with nonrecipients. They also compared the cohorts with regard to rates of prescription fills for opioids and associated charges. RESULTS: The adjusted likelihood of filling a prescription for an opioid analgesic was 55% lower among recipients compared with nonrecipients (odds ratio 0.45; 95% confidence interval 0.40-0.47; p < 0.0001). Average charges per person for opioid prescriptions were also significantly lower among recipients. CONCLUSIONS: Among New Hampshire adults with office visits for noncancer low-back pain, the likelihood of filling a prescription for an opioid analgesic was significantly lower for recipients of services delivered by doctors of chiropractic compared with nonrecipients. The underlying cause of this correlation remains unknown, indicating the need for further investigation.


Asunto(s)
Analgésicos Opioides/uso terapéutico , Prescripciones de Medicamentos/estadística & datos numéricos , Dolor de la Región Lumbar/epidemiología , Dolor de la Región Lumbar/terapia , Manipulación Quiropráctica/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , New Hampshire/epidemiología , Estudios Retrospectivos , Adulto Joven
3.
Environ Health Perspect ; 117(11): 1718-23, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20049123

RESUMEN

BACKGROUND: Little is known about the carcinogenic potential of arsenic in areas with low to moderate concentrations of arsenic (< 100 microg/L) in drinking water. OBJECTIVES: We examined associations between arsenic and lung cancer. METHODS: A population-based case-control study of primary incident lung cancer was conducted in 10 counties in two U.S. states, New Hampshire and Vermont. The study included 223 lung cancer cases and 238 controls, each of whom provided toenail clippings for arsenic exposure measurement by inductively coupled-plasma mass spectrometry. We estimated odds ratios (ORs) of the association between arsenic exposure and lung cancer using unconditional logistic regression with adjustment for potential confounders (age, sex, race/ethnicity, smoking pack-years, education, body mass index, fish servings per week, and toenail selenium level). RESULTS: Arsenic exposure was associated with small-cell and squamous-cell carcinoma of the lung [OR = 2.75; 95% confidence interval (CI), 1.00-7.57] for toenail arsenic concentration > or = 0.114 microg/g, versus < 0.05 microg/g. A history of lung disease (bronchitis, chronic obstructive pulmonary disease, or fibrosis) was positively associated with lung cancer (OR = 2.86; 95% CI, 1.39-5.91). We also observed an elevated risk of lung cancer among participants with a history of lung disease and toenail arsenic > or = 0.05 microg/g (OR = 4.78; 95% CI, 1.87-12.2) than among individuals with low toenail arsenic and no history of lung disease. CONCLUSION: Although this study supports the possibility of an increased risk of specific lung cancer histologic types at lower levels of arsenic exposure, we recommend large-scale population-based studies.


Asunto(s)
Arsénico/toxicidad , Exposición a Riesgos Ambientales/efectos adversos , Neoplasias Pulmonares/epidemiología , Contaminantes Químicos del Agua/toxicidad , Adulto , Anciano , Arsénico/análisis , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/patología , Estudios de Casos y Controles , Femenino , Humanos , Modelos Logísticos , Enfermedades Pulmonares/complicaciones , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Uñas/química , New Hampshire/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Selenio/metabolismo , Carcinoma Pulmonar de Células Pequeñas/inducido químicamente , Carcinoma Pulmonar de Células Pequeñas/epidemiología , Carcinoma Pulmonar de Células Pequeñas/patología , Espectrofotometría Atómica , Vermont/epidemiología , Contaminantes Químicos del Agua/análisis
4.
Cancer Lett ; 251(1): 43-52, 2007 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-17194528

RESUMEN

There is considerable interest in herbal therapies for cancer prevention but often with little scientific evidence to support their use. In this study, we examined epidemiological data regarding effects of commonly used herbal supplements on risk for ovarian cancer and sought supporting biological evidence. 4.2% of 721 controls compared to 1.6% of 668 cases regularly used Ginkgo biloba for an estimated relative risk (and 95% confidence interval) of 0.41 (0.20,0.84) (p=0.01); and the effect was most apparent in women with non-mucinous types of ovarian cancer, RR=0.33 (0.15,0.74) (p=0.007). In vitro experiments with normal and ovarian cancer cells showed that Ginkgo extract and its components, quercetin and ginkgolide A and B, have significant anti-proliferative effects ( approximately 40%) in serous ovarian cancer cells, but little effect in mucinous (RMUG-L) cells. For the ginkgolides, the inhibitory effect appeared to be cell cycle blockage at G0/G1 to S phase. This combined epidemiological and biological data provide supportive evidence for further studies of the chemopreventive or therapeutic effects of Ginkgo and ginkgolides on ovarian cancer.


Asunto(s)
Ginkgo biloba/química , Neoplasias Ováricas/prevención & control , Extractos Vegetales/uso terapéutico , Estudios de Casos y Controles , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Cromatografía Liquida , Cistadenocarcinoma Mucinoso/epidemiología , Cistadenocarcinoma Mucinoso/patología , Cistadenocarcinoma Mucinoso/prevención & control , Relación Dosis-Respuesta a Droga , Femenino , Ginkgólidos/sangre , Ginkgólidos/farmacología , Ginkgólidos/uso terapéutico , Humanos , Lactonas/sangre , Lactonas/farmacología , Lactonas/uso terapéutico , Modelos Logísticos , Espectrometría de Masas , Massachusetts/epidemiología , New Hampshire/epidemiología , Neoplasias Ováricas/epidemiología , Neoplasias Ováricas/patología , Fitoterapia/estadística & datos numéricos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Quercetina/sangre , Quercetina/farmacología , Quercetina/uso terapéutico
5.
J Natl Cancer Inst ; 94(3): 224-6, 2002 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-11830612

RESUMEN

Use of artificial tanning devices that emit UV radiation, such as tanning lamps and tanning beds, has become increasingly popular in the United States. Although an excess risk of nonmelanoma skin cancers might be predicted from this exposure, little epidemiologic data exist. We conducted a population-based, case-control study that included 603 basal cell carcinoma (BCC) case patients, 293 squamous cell carcinoma (SCC) case patients, and 540 control subjects. Study participants were interviewed in person to obtain information on tanning device use, sun exposure history, sun sensitivity, and other risk factors for skin cancer. Overall, any use of tanning devices was associated with odds ratios of 2.5 (95% confidence interval [CI] = 1.7 to 3.8) for SCC and 1.5 (95% CI = 1.1 to 2.1) for BCC. Adjustment for history of sunburns, sunbathing, and sun exposure did not affect our results. Our findings suggest that the use of tanning devices may contribute to the incidence of nonmelanoma skin cancers. They highlight the need to further evaluate the potential risks of BCC and SCC that are associated with tanning lamp exposure and the appropriate public health response.


Asunto(s)
Neoplasias Basocelulares/etiología , Neoplasias de Células Escamosas/etiología , Neoplasias Cutáneas/etiología , Rayos Ultravioleta/efectos adversos , Adulto , Factores de Edad , Anciano , Femenino , Helioterapia/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Basocelulares/epidemiología , Neoplasias de Células Escamosas/epidemiología , New Hampshire/epidemiología , Oportunidad Relativa , Factores de Riesgo , Caracteres Sexuales , Neoplasias Cutáneas/epidemiología , Factores Socioeconómicos , Quemadura Solar
6.
Int J Cancer ; 88(2): 313-8, 2000 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-11004686

RESUMEN

Coffee, alcohol and tobacco use have been examined in many epidemiologic studies of ovarian cancer but findings have generally been inconclusive. To explain prior inconsistent findings, we sought to determine whether associations with these exposures might vary by histologic subtype of ovarian cancer or menopausal status at diagnosis. We conducted a population-based case-control study in eastern Massachusetts and New Hampshire involving 549 women with newly-diagnosed epithelial ovarian cancer and 516 control women selected either by random digit dialing or through lists of residents. Coffee and alcohol consumption was assessed through a semi-quantitative food-frequency questionnaire, and information on tobacco smoking was collected through personal interview. Consumption of coffee and caffeine was associated with increased risk for ovarian cancer but only among premenopausal women. There was no increase in risk for ovarian cancer overall associated with tobacco or alcohol use in either pre- or post-menopausal women. Association of borderline significance for tobacco and invasive serous cancers and alcohol and mucinous cancers were observed but reduced after adjustment for coffee consumption. We conclude that coffee and caffeine consumption may increase risk for ovarian cancer among premenopausal women and are findings that have some epidemiologic and biologic support.


Asunto(s)
Consumo de Bebidas Alcohólicas , Cafeína , Café , Neoplasias Ováricas/epidemiología , Fumar , Adulto , Anciano , Bebidas Gaseosas , Estudios de Casos y Controles , Familia , Femenino , Humanos , Massachusetts/epidemiología , Persona de Mediana Edad , New Hampshire/epidemiología , Neoplasias Ováricas/genética , Medición de Riesgo , Factores de Riesgo ,
7.
Rev Invest Clin ; 42(4): 312-6, 1990.
Artículo en Español | MEDLINE | ID: mdl-2091182

RESUMEN

The carcinogenic effects of ionizing radiation at high doses are un questionable. On the other hand, the deleterious exposure effects to low doses have not been totally proven, mainly due to methodological problems and difficulty in measuring reliable dose exposure. In this paper, some recent studies examining the effects of ionizing radiation in some occupational groups are reviewed and discussed. Also, the main areas of epidemiologic controversy are stressed. For future experiences, prospective, longitudinal studies with occupational cohorts, measuring radiation exposure with adequate registry and follow-up, are suggested.


Asunto(s)
Neoplasias Inducidas por Radiación/epidemiología , Radiación de Fondo , Estudios de Casos y Controles , Estudios de Cohortes , Exposición a Riesgos Ambientales , Humanos , Tablas de Vida , Neoplasias Inducidas por Radiación/etiología , New Hampshire/epidemiología , Reactores Nucleares , Enfermedades Profesionales/epidemiología , Enfermedades Profesionales/etiología , Enfermedades Profesionales/mortalidad , Exposición Profesional , Centrales Eléctricas , Modelos de Riesgos Proporcionales , Dosis de Radiación , Tennessee/epidemiología , Uranio , Washingtón/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA